Chahrazade El Amri

Prof. Dr. Chahrazade El Amri

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2009 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
PNPierre Nicolas
Pierre Nicolas
CAChahrazade El Amri
Chahrazade El Amri

1 April 2010 in Antiviral Research
Verified
Journal Article
Closed access
DDDominique Deville-Bonne
Dominique Deville-Bonne
CAChahrazade El Amri
Chahrazade El Amri
PMPhilippe Meyer
Philippe Meyer
YCYuxing Chen
Yuxing Chen
Luigi AgrofoglioLuigi Agrofoglio
Luigi Agrofoglio
JJJoël Janin
Joël Janin

1 September 2009 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
PJPierre Joanne
Pierre Joanne
CGCécile Galanth
Cécile Galanth
NGNicole Goasdoué
Nicole Goasdoué
PNPierre Nicolas
Pierre Nicolas
SSSandrine SAGAN
Sandrine SAGAN
Isabel AlvesIsabel Alves
Isabel Alves

22 December 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XTXiao Tan
Xiao Tan
FSFeryel Soualmia
Feryel Soualmia
LFLaetitia Furio
Laetitia Furio
JRJean-François Renard
Jean-François Renard
IKIsabelle Kempen
Isabelle Kempen
MRMichèle Reboud-Ravaux
Michèle Reboud-Ravaux

Verified
Journal Article
Open access
PDF file
KHKhadija El Hadri
Khadija El Hadri
RSRémy Smith
Rémy Smith
EDEric Duplus
Eric Duplus
CAChahrazade El Amri
Chahrazade El Amri
Atherosclerosis is a leading cause of cardiovascular diseases (CVD) worldwide and intimately linked to aging. This pathology is characterized by chronic inflammation, oxidative stress, gradual accumulation of low-density lipoproteins (LDL) particles and fibrous elements in focal areas of large and medium arteries. These fibrofatty lesions in the artery wall become progressively unstable and thrombogenic leading to heart attack, stroke or other severe heart ischemic syndromes. Elevated blood levels of LDL are major triggering events for atherosclerosis. A cascade of molecular and cellular events results in the atherosclerotic plaque formation, evolution, and rupture. Moreover, the senescence of multiple cell types present in the vasculature were reported to contribute to atherosclerotic plaque progression and destabilization. Classical therapeutic interventions consist of lipid-lowering drugs, anti-inflammatory and life style dispositions. Moreover, targeting oxidative stress by developing innovative antioxidant agents or boosting antioxidant systems is also a well-established strategy. Accumulation of senescent cells (SC) is also another important feature of atherosclerosis and was detected in various models. Hence, targeting SCs appears as an emerging therapeutic option, since senolytic agents favorably disturb atherosclerotic plaques. In this review, we propose a survey of the impact of inflammation, oxidative stress, and senescence in atherosclerosis; and the emerging therapeutic options, including thioredoxin-based approaches such as anti-oxidant, anti-inflammatory, and anti-atherogenic strategy with promising potential of senomodulation.

3 December 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
DTDimitri Topalis
Dimitri Topalis
UPUgo Pradère
Ugo Pradère
VRVincent Roy
Vincent Roy
CCChristophe Caillat
Christophe Caillat
AAAhmed Azzouzi
Ahmed Azzouzi
Luigi AgrofoglioLuigi Agrofoglio
Luigi Agrofoglio